Xiaofeng Niu

1PUBLICATIONS
0CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (1)

|Sep 11, 2024
A pan-allelic human SIRPĪ±-blocking antibody, ES004-B5, promotes tumor killing by enhancing macrophage phagocytosis and subsequently inducing an effective T-cell response.

Xiaofeng Niu, Chunnian Wang, Haixia Jiang

Pageof 1

Frequent Collaborators